AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zensita M 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Zuventus Healthcare Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Zensita M 50mg/1000mg Tablet

Diabex Duo 50mg/1000mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney failure and vision loss, potentially lowering heart attack and stroke risk. Diabex Duo may be used alone or with other diabetes treatments, and works optimally with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and other medications. Consuming it with food minimizes stomach upset. Consistent daily dosing, at the same time each day, maximizes effectiveness; discontinue only under your doctor's guidance. Maintaining your prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect when combined with insulin or sulfonylureas; learn to recognize and manage this. This medication isn't for everyone. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals should seek medical advice. Other medications can interact with Diabex Duo; disclose all medications to ensure safety. Limit alcohol intake due to its blood sugar-lowering effects. Your physician will monitor your kidney function and blood sugar levels throughout treatment.

Uses of Zensita M 50mg/1000mg Tablet

Managing Type 2 Diabetes

Major Benefits of Zensita M 50mg/1000mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Zensita M 50mg/1000mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Zensita M 50mg/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Zensita M 50mg/1000mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Zensita M 50mg/1000mg tablet should be administered with a meal.

How Zensita M 50mg/1000mg Tablet works:

Zensita M, a 50mg/1000mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Zensita M 50mg/1000mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zensita M 50mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Zensita M 50mg/1000mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Zensita M 50mg/1000mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Zensita M 50mg/1000mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverUNSAFE

The use of Zensita M 50mg/1000mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted unless specifically directed by a physician. Seek medical advice before use.

What if you forget to take Zensita M 50mg/1000mg Tablet :

Should you forget a Zensita M 50mg/1000mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zensita M 50mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Zensita M 50mg/1000mg Tablet

Zensita M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Zensita M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Zensita M 50mg/1000mg tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Zensita M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Zensita M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Zensita M 50mg/1000mg tablets. This occurs due to excessive lactic acid buildup in the blood. Because it's rare, metformin is avoided in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Zensita M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Zensita M 50mg/1000mg tablets may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Zensita M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Zensita M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of Zensita M 50mg/1000mg tablets. This occurs due to a buildup of lactic acid in the blood. Because it's rare, metformin is avoided in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Zensita M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Zensita M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Zensita M 50mg/1000mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Zensita M 50mg/1000mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Zensita M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA – Metformin-associated lactic acidosis), is a potential side effect of Zensita M 50mg/1000mg Tablets. This occurs due to excess lactic acid in the bloodstream and is rare, but more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these, discontinue Zensita M and seek immediate medical attention.
Prolonged use of Zensita M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 intake is recommended annually by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Zensita M 50mg/1000mg Tab...
187